Free Trial

Short Interest in Cresco Labs Inc. (OTCMKTS:CRLBF) Grows By 5.7%

Cresco Labs logo with Medical background

Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) saw a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 805,300 shares, a growth of 5.7% from the November 15th total of 762,000 shares. Based on an average daily trading volume, of 1,541,300 shares, the days-to-cover ratio is currently 0.5 days.

Wall Street Analyst Weigh In

CRLBF has been the subject of a number of research reports. Atb Cap Markets downgraded Cresco Labs from a "strong-buy" rating to a "hold" rating in a report on Monday, December 9th. Cormark downgraded Cresco Labs from a "moderate buy" rating to a "hold" rating in a research note on Monday, November 11th. Finally, Roth Capital raised shares of Cresco Labs to a "strong-buy" rating in a report on Sunday, November 10th. Four investment analysts have rated the stock with a hold rating, two have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Cresco Labs has an average rating of "Moderate Buy" and an average price target of $2.50.

View Our Latest Research Report on CRLBF

Cresco Labs Price Performance

Shares of OTCMKTS:CRLBF traded down $0.05 during midday trading on Monday, hitting $0.95. The company had a trading volume of 1,258,428 shares, compared to its average volume of 759,631. The business's 50-day simple moving average is $1.35 and its 200-day simple moving average is $1.56. The stock has a market cap of $464.42 million, a price-to-earnings ratio of -4.76 and a beta of 1.73. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.97 and a quick ratio of 1.39. Cresco Labs has a twelve month low of $0.93 and a twelve month high of $2.65.

Cresco Labs Company Profile

(Get Free Report)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Read More

→ A conspiracy Trump won’t unseal (From Porter & Company) (Ad)

Should you invest $1,000 in Cresco Labs right now?

Before you consider Cresco Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.

While Cresco Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines